Andrea M. Burden

Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study

Judith van Dalem, Martijn C.G.J. Brouwers, Coen D.A. Stehouwer et al. · BMJ · 2016 · 90 citations · Full text

Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS)

Annika Vestergaard Kvist, Junaid Faruque, Enriqueta Vallejo‐Yagüe et al. · Journal of Clinical Medicine · 2021 · 77 citations · Full text

Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis

Johanna H. M. Driessen, Ronald M.A. Henry, Hein A. W. van Onzenoort et al. · Calcified Tissue International · 2015 · 72 citations · Full text

Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs

Johanna H. M. Driessen, Hein A. W. van Onzenoort, Jakob Starup‐Linde et al. · Calcified Tissue International · 2015 · 71 citations · Full text

Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study

Mohamed Amiche, Shahab Abtahi, Johanna H. M. Driessen et al. · Archives of Osteoporosis · 2018 · 64 citations · Full text